CDSCO drafts guidelines on recall and rapid alert system for drugs including biologics and vaccines Read more
TauRx Therapeutics initiates two global Phase III clinical trials in mild to moderate Alzheimer’s disease Read more
Novartis to construct biotechnology facility in Singapore with an investment of over $500 million Read more